BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23772077)

  • 1. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three rheumatoid arthritis disease activity scores in clinical routine.
    Rintelen B; Sautner J; Haindl PM; Andel I; Maktari A; Leeb BF
    Scand J Rheumatol; 2009; 38(5):336-41. PubMed ID: 19585379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study.
    Burmester GR; Ferraccioli G; Flipo RM; Monteagudo-Sáez I; Unnebrink K; Kary S; Kupper H
    Arthritis Rheum; 2008 Jan; 59(1):32-41. PubMed ID: 18163417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
    Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
    Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T; Dernoschnig F; Machold KP; Stamm T; Schoels M; Smolen JS; Aletaha D
    Arthritis Res Ther; 2007; 9(4):R72. PubMed ID: 17662115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research.
    Bentley MJ; Greenberg JD; Reed GW
    J Rheumatol; 2010 Aug; 37(8):1607-14. PubMed ID: 20595282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
    Balsa A; Carmona L; González-Alvaro I; Belmonte MA; Tena X; Sanmartí R;
    J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived joint counts are a potential alternative for determining Disease Activity Score.
    Kavanaugh A; Lee SJ; Weng HH; Chon Y; Huang XY; Lin SL
    J Rheumatol; 2010 May; 37(5):1035-41. PubMed ID: 20156946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission.
    Landewé R; van der Heijde D; van der Linden S; Boers M
    Ann Rheum Dis; 2006 May; 65(5):637-41. PubMed ID: 16219709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
    Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
    J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
    Mäkinen H; Kautiainen H; Hannonen P; Sokka T
    Ann Rheum Dis; 2005 Oct; 64(10):1410-3. PubMed ID: 15941836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.